Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course intensified insulin treatment for remission or oral therapy responsiveness in newly diagnosed type 2 diabetes
2011-001509-28Phase 4Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Dec 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin lispro and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Change in beta-cell glucose sensitivity. Started Dec 2011; status: completed.
02
Drugs
insulin lisprometformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-001509-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001509-28.